The Global Blood Screening Market accounted to USD 1.94 billion in 2016 growing at a CAGR of 9.70% during the forecast period of 2017 to 2024
- Advertising -
Global Blood Screening Market, By Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024 Global Blood Screening Market Analysis:
The upcoming market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Full Report : databridgemarketresearch.com/repor…-market/ Major Market Drivers and Restraints:
Increase in blood donation
Rising awareness towards transfusion transmitted disease
Growing incidence of infectious disease
Adoption and affordability ofnucleic acid amplification test (NAT) during test.
Report : databridgemarketresearch.com/toc/?…g-market Global Blood Screening Market Segmentation:
On the basis of technology, global blood screening market is segmented intonucleic acid amplification, reverse polymerase chain reaction (RPCR), rapid test, NGS and western blotting. ELISA is further segmented into CLIA and fluorescence assay.
- Advertising -
On the basis of product, global blood screening market is segmented into instrument, reagent & Kits, and software. Here, kits and software held the largest market share because of rise in consumption as well as due to its repetitive use.
On the basis of end user, global blood screening market is segmented into blood bank and hospitals. In 2016, blood bank accounted the largest market share due to increasing demand and transplantation surgeries and rise in government funding to different charitable trust.
On the basis of geography, global blood screening market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.
In 2017, North America is expected to dominate the market.
Report: databridgemarketresearch.com/speak…g-market Global Blood Screening Market Competitive Analysis:
The global blood screening market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes blood screening market shares for global, Europe, North America, Asia Pacific, and South America.
Major Market Competitors:
Some of the major players operating in global blood screening market are Grifols (Spain), F. Hoffmann –La Roche Ltd. (Switzerland), Abbott (U.S.), Siemens Medical Solutions (Germany), Thermo Fisher Scientific, Inc.
(U.S.), bioMérieux (France), Ortho Clinical Diagnostics, (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc.
(U.S.), Alere Inc. (U.S.), Meridian Bioscience Inc. (U.S.), Enzo Biochem Inc. (U.S.), Lab21(U.K.), and Cepheid (U.S.), among others.
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: